| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Laboratory of Cellular Carcinogenesis and Tumor Promotion, Division of Cancer Etiology, National Cancer Institute, Bethesda, Maryland 20892
Staurosporine is a potent but nonselective inhibitor of protein kinase C (PKC) and blocks responses to 12-O-tetradecanoylphorbol-13-acetate (TPA) in several cell types in vitro. In cultured primary mouse keratinocytes, however, staurosporine fails to inhibit TPA-mediated keratinocyte maturation and itself elicits responses that are similar to TPA (T. Sako et al., Cancer Res., 48: 46464650, 1988). After exposure to 10 nM staurosporine for 24 h, essentially all keratinocytes undergo morphological differentiation, whereas 160 nM TPA induces this response in about 50% of epidermal cells. These concentrations of staurosporine and TPA cause a 45-fold induction of epidermal transglutaminase activity and cornified envelopes, both markers of the terminal stage of keratinocyte differentiation. Staurosporine, but not TPA, also induces morphological and biochemical maturation in 2 neoplastic mouse keratinocyte cell lines, 308 and SP-1. The ability of staurosporine to elicit the same responses as TPA suggested that it may be functioning paradoxically as a PKC agonist in intact keratinocytes. In support of this hypothesis, staurosporine induces ornithine decarboxylase activity, inhibits 125I-labeled epidermal growth factor binding, and induces expression of c-fos mRNA. Downregulation of PKC by pretreatment of primary keratinocytes with 60 nM bryostatin partially blocks staurosporine-mediated induction of cornified envelopes and inhibition of 125I-labeled epidermal growth factor binding, implicating PKC in these responses. The ability of staurosporine to mimic and/or enhance certain responses to TPA suggests that this agent is acting as a functional PKC agonist in cultured keratinocytes.
1 Recipient of a Physician's Research Training Fellowship (PRTF-98) from the American Cancer Society.
2 To whom requests for reprints should be addressed, at Laboratory of Cellular Carcinogenesis and Tumor Promotion, Division of Cancer Etiology, National Cancer Institute, Building 37/Room 3B25, Bethesda, MD 20892.
Received 3/26/91. Accepted 6/14/91.
This article has been cited by other articles:
![]() |
L. Koivisto, K. Alavian, L. Hakkinen, S. Pelech, C. A. McCulloch, and H. Larjava Glycogen synthase kinase-3 regulates formation of long lamellipodia in human keratinocytes J. Cell Sci., September 15, 2003; 116(18): 3749 - 3760. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. A. Shapiro, S. Ray, E. Jung, W. T. Allred, and W. B. Bollag Putative Conventional Protein Kinase C Inhibitor Godecke 6976 [12-(2-Cyanoethyl)-6,7,12,13-tetrahydro-13-methyl-5-oxo-5H-indolo(2,3-a)pyrrolo(3,4-c)-carbazole] Stimulates Transglutaminase Activity in Primary Mouse Epidermal Keratinocytes J. Pharmacol. Exp. Ther., July 1, 2002; 302(1): 352 - 358. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Li, P. S. Lorenzo, K. Bogi, P. M. Blumberg, and S. H. Yuspa Protein Kinase Cdelta Targets Mitochondria, Alters Mitochondrial Membrane Potential, and Induces Apoptosis in Normal and Neoplastic Keratinocytes When Overexpressed by an Adenoviral Vector Mol. Cell. Biol., December 1, 1999; 19(12): 8547 - 8558. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Jung, S. Betancourt-Calle, R. Mann-Blakeney, R. D. Griner, and W. B. Bollag Sustained phospholipase D activation is associated with keratinocyte differentiation Carcinogenesis, April 1, 1999; 20(4): 569 - 576. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Pedron, R. Girard, K. Inoue, D. Charon, and R. Chaby Lipopolysaccharide and the Glycoside Ring of Staurosporine Induce CD14 Expression on Bone Marrow Granulocytes by Different Mechanisms Mol. Pharmacol., October 1, 1997; 52(4): 692 - 700. [Abstract] [Full Text] |
||||
![]() |
U. Gundimeda, Z.-H. Chen, and R. Gopalakrishna Tamoxifen Modulates Protein Kinase C via Oxidative Stress in Estrogen Receptor-negative Breast Cancer Cells J. Biol. Chem., June 7, 1996; 271(23): 13504 - 13514. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |